Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy
- PMID: 27528718
- DOI: 10.1200/JCO.2016.67.9647
Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy
Abstract
Purpose: We aimed to update a previously published, multi-institutional nomogram of outcomes for salvage radiotherapy (SRT) following radical prostatectomy (RP) for prostate cancer, including patients treated in the contemporary era.
Methods: Individual data from node-negative patients with a detectable post-RP prostate-specific antigen (PSA) treated with SRT with or without concurrent androgen-deprivation therapy (ADT) were obtained from 10 academic institutions. Freedom from biochemical failure (FFBF) and distant metastases (DM) rates were estimated, and predictive nomograms were generated.
Results: Overall, 2,460 patients with a median follow-up of 5 years were included; 599 patients (24%) had a Gleason score (GS) ≤ 6, 1,387 (56%) had a GS of 7, 244 (10%) had a GS of 8, and 230 (9%) had a GS of 9 to 10. There were 1,370 patients (56%) with extraprostatic extension (EPE), 452 (18%) with seminal vesicle invasion (SVI), 1,434 (58%) with positive surgical margins, and 390 (16%) who received ADT (median, 6 months). The median pre-SRT PSA was 0.5 ng/mL (interquartile range, 0.3 to 1.1). The 5-yr FFBF rate was 56% overall, 71% for those with a pre-SRT PSA level of 0.01 to 0.2 ng/mL (n = 441), 63% for those with a PSA of 0.21 to 0.50 ng/mL (n = 822), 54% for those with a PSA of 0.51 to 1.0 ng/mL (n = 533), 43% for those with a PSA of 1.01 to 2.0 ng/mL (n = 341), and 37% for those with a PSA > 2.0 ng/mL (n = 323); P < .001. On multivariable analysis, pre-SRT PSA, GS, EPE, SVI, surgical margins, ADT use, and SRT dose were associated with FFBF. Pre-SRT PSA, GS, SVI, surgical margins, and ADT use were associated with DM, whereas EPE and SRT dose were not. The nomogram concordance indices were 0.68 (FFBF) and 0.74 (DM).
Conclusion: Early SRT at low PSA levels after RP is associated with improved FFBF and DM rates. Contemporary nomograms can estimate individual patient outcomes after SRT in the modern era.
Comment in
-
Reply to T. Seisen et al and P. Ghadjar et al.J Clin Oncol. 2017 May 1;35(13):1491-1492. doi: 10.1200/JCO.2016.70.7992. Epub 2017 Jan 30. J Clin Oncol. 2017. PMID: 28135134 No abstract available.
-
Is Dose-Intensified Salvage Radiation Therapy After Prostatectomy Beneficial?J Clin Oncol. 2017 May 1;35(13):1490-1491. doi: 10.1200/JCO.2016.70.7265. Epub 2017 Jan 30. J Clin Oncol. 2017. PMID: 28135138 No abstract available.
-
Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectomy: Is Earlier Always Better?J Clin Oncol. 2017 May 1;35(13):1489-1490. doi: 10.1200/JCO.2016.70.6879. Epub 2017 Jan 30. J Clin Oncol. 2017. PMID: 28135149 No abstract available.
Similar articles
-
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy.Eur Urol Oncol. 2022 Jun;5(3):304-313. doi: 10.1016/j.euo.2021.04.011. Epub 2021 May 18. Eur Urol Oncol. 2022. PMID: 34016556
-
Ten-Year Outcomes of Moderately Hypofractionated Salvage Postprostatectomy Radiation Therapy and External Validation of a Contemporary Multivariable Nomogram for Biochemical Failure.Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):288-296. doi: 10.1016/j.ijrobp.2020.01.008. Epub 2020 Jan 25. Int J Radiat Oncol Biol Phys. 2020. PMID: 31987961
-
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate Cancer.JAMA Netw Open. 2023 May 1;6(5):e2314748. doi: 10.1001/jamanetworkopen.2023.14748. JAMA Netw Open. 2023. PMID: 37219907 Free PMC article.
-
Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.Strahlenther Onkol. 2018 Jul;194(7):619-626. doi: 10.1007/s00066-018-1269-3. Epub 2018 Jan 30. Strahlenther Onkol. 2018. PMID: 29383406 Review. English.
-
[Adjuvant vs. salvage radiotherapy after radical prostatectomy].Aktuelle Urol. 2015 Jan;46(1):52-8. doi: 10.1055/s-0034-1395656. Epub 2015 Feb 6. Aktuelle Urol. 2015. PMID: 25658231 Review. German.
Cited by
-
Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience.Radiat Oncol. 2021 May 12;16(1):88. doi: 10.1186/s13014-021-01808-3. Radiat Oncol. 2021. PMID: 33980277 Free PMC article. Clinical Trial.
-
How can we best manage biochemical failure after radical prostatectomy?Investig Clin Urol. 2022 Nov;63(6):592-601. doi: 10.4111/icu.20220294. Investig Clin Urol. 2022. PMID: 36347548 Free PMC article. Review.
-
An Integrative Multi-Omics Analysis Based on Nomogram for Predicting Prostate Cancer Bone Metastasis Incidence.Genet Res (Camb). 2022 Sep 29;2022:8213723. doi: 10.1155/2022/8213723. eCollection 2022. Genet Res (Camb). 2022. PMID: 36245556 Free PMC article.
-
Therapeutic options in patients with biochemical recurrence after radical prostatectomy.Exp Ther Med. 2019 Dec;18(6):5021-5025. doi: 10.3892/etm.2019.7916. Epub 2019 Aug 20. Exp Ther Med. 2019. PMID: 31798723 Free PMC article. Review.
-
Multimodality Therapies for Localized Prostate Cancer.Curr Oncol Rep. 2023 Mar;25(3):221-229. doi: 10.1007/s11912-023-01374-9. Epub 2023 Feb 1. Curr Oncol Rep. 2023. PMID: 36723856 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous